Jim Gallagher

Blog

靶向放射治疗的剂量优化考量

The acquisitions of targeted radiation therapy companies (TRT) Point Biopharma by Eli Lilly and RayzeBio…

Jim Gallagher2024 年 2 月 16 日

Publication

The interaction of core modules as a basis for elucidating network behavior determining Parkinson’s disease pathogenesis

It is well-established that misfolded alpha-synuclein (alpha-syn) is a histopathological marker of Parkinson's disease. Given…

Jim Gallagher2024 年 2 月 14 日

Article

Upping the Ante for Predicting the Success of Alzheimer Disease Treatments

By Hugo Geerts, PhD, Piet van der Graaf, PharmD, PhD Over the past 20 years,…

Jim Gallagher2024 年 2 月 8 日

Conference

DIA MASC

Jim Gallagher2024 年 2 月 2 日

Conference

Phuse US Connect

Conference: Phuse US Connect Date: March 16-19, 2025 Location: Orlando, Florida Booth: A Sponsor: Platinum…

Jim Gallagher2024 年 1 月 31 日

Blog

为医疗保健产品的市场准入导航：全球价值档案的力量

This blog defines the global value dossiers and explains how BaseCase can support creating interactive…

Jim Gallagher2024 年 1 月 24 日

Blog

了解发现资产目标产品简介的作用

If you work at a biotechnology start-up, you’re probably excited about your compound assets, particularly…

Jim Gallagher2024 年 1 月 19 日

Publication

Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database

To assess real-world treatment patterns in patients diagnosed with hormone receptor positive (HR+), human epidermal…

Jim Gallagher2024 年 1 月 17 日

Publication

Real-world application of PBPK in drug discovery

The utility of PBPK models in support of drug development has been well documented. During…

Jim Gallagher2024 年 1 月 11 日

Article

MedCity News | How the IRA Has Created a New Environment for Biosimilars

By Maximillian Vargas and Caitlin Verrilli As IRA provisions are activated, the law’s impact on…

Jim Gallagher2024 年 1 月 5 日

Jim Gallagher

靶向放射治疗的剂量优化考量

The interaction of core modules as a basis for elucidating network behavior determining Parkinson’s disease pathogenesis

Upping the Ante for Predicting the Success of Alzheimer Disease Treatments

DIA MASC

Phuse US Connect

为医疗保健产品的市场准入导航：全球价值档案的力量

了解发现资产目标产品简介的作用

Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database

Real-world application of PBPK in drug discovery

MedCity News | How the IRA Has Created a New Environment for Biosimilars

订阅时事通讯

快捷链接

解决方案

联系我们